NeuroFine Corp.
About
Issuer
- Entity type
- Corporation
- Jurisdiction
- Delaware
- Sector
- Healthtech
- Headquarters
- Miramar, FL
- Street
- 10370 USA Today Way
- Zip
- 33025
Offering
- Total offering
- $1M
- Amount sold
- $1M
- First sale
- Mar 23, 2026
- Min investment
- $0
- Securities
- Equity
- Federal exemption
- Rule 506(b)
- Investors so far
- 14
How this filing compares
Ranked #41 of 63 Healthtech filings in April 2026 by offering amount.
Median Healthtech filing in April 2026: $3.4M. This offering is 0.3× the median.
Other Florida filings this week: Be Belong Group Corp., Collaborative Fund I - Charlotte Square Income, LP, MACE & SHIELD INVEST LP, MOSIR INVESTMENTS REIT LLC, NFluxion Inc
Leadership
Ajay Wakhloo — Executive Officer (also: Director)
Also named on: Prometheus Therapeutics Inc.
Bernie Navarro — Executive Officer
Also named on: Prometheus Therapeutics Inc.
Marc Litzenberg — Director
Daniel Sablyak — Director
John McEleney — Director
Also named on: Prometheus Therapeutics Inc.
Filing details
NeuroFine Corp. filed a Form D with the SEC on April 8, 2026.